Skip to main content

Table 8 Correlation between and baseline carotid IMT and other risk factors

From: Assessment of carotid atherosclerosis in Egyptian chronic hepatitis C patients after treatment by direct-acting antiviral drugs

  Carotid IMT
r p-value
Age 0.612  < 0.001*
BMI 0.263 .019*
Systolic BP 0.128 0.257
Diastolic BP .031 0.782
Pulse .023 0.837
Hb  − 0.400  < 0.001*
WBCs  − .083 0.466
Platelets  − 0.638  < 0.001*
ALT .054 0.632
AST .047 0.678
Albumin  − 0.790  < 0.001*
Bilirubin 0.782  < 0.001*
INR 0.352 0.001*
CTP score 0.846  < 0.001*
HCV RNA .088 0.437
TC 0.357 0.001*
TGs  − 0.129 0.254
LDL  − .070 0.539
HDL  − 0.418  < 0.001*
S. creatinine  − .062 0.586
Urea  − .052 0.647
RBS .002 0.989
AFP .092 0.417
Carotid plaques 0.290 0.009
  1. p ≤ 0.05 is considered statistically significant; p ≤ 0.01* is considered highly statistically significant. In non-SVR patients, there was no statistically significant difference in total cholesterol, triglycerides, LDL, and HDL at baseline and follow-up (p > 0.05), while in SVR group, total cholesterol, triglycerides, LDL, and HDL were significantly increased after follow-up compared to baseline (p < 0.001). It was noticed that LDL was significantly higher in SVR group compared to non-SVR after treatment (p = 0.034). Also, carotid IMT was significantly lower in SVR group compared to non-SVR (p = 0.016)